J9381 Injection teplizumab mzwv 5 micrograms
Also known as: teplizumab, Provysio
Injection of teplizumab mzwv, 5 microgram. A T-cell receptor-engaging anti-CD3 monoclonal antibody for type 1 diabetes prevention.
In Plain Language
diabetes prevention injection; immune tolerance induction
Clinical Context
Used to delay onset of type 1 diabetes in at-risk individuals. CD3-engaging antibody inducing immune tolerance.
RVU Information
CPT J9381 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9381?
CPT J9381 (Injection teplizumab mzwv 5 micrograms) is a J Codes (Drugs) code. Injection of teplizumab mzwv, 5 microgram. A T-cell receptor-engaging anti-CD3 monoclonal antibody for type 1 diabetes prevention.
How is J9381 administered?
CPT J9381 is administered by a healthcare provider, typically via injection or infusion. Used to delay onset of type 1 diabetes in at-risk individuals. CD3-engaging antibody inducing immune tolerance. It is used by Endocrinology, Immunology, Internal Medicine.
When is CPT J9381 used?
Used to delay onset of type 1 diabetes in at-risk individuals. CD3-engaging antibody inducing immune tolerance.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.